Article information
Full text is only aviable in PDF
REFERENCES
[1]
R Rodríguez-Roisin.
Toward a consensus definition for COPD exacerbations.
Chest, 117 (2000), pp. 398S-401S
[2]
American Thoracic Society.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med., 152 (1995), pp. S77-S121
[3]
The COPD Guidelines Group of the Standards of Care Committee of the BTS.
BTS guidelines for the management of chronic obstructive pulmonary disease.
Thorax, 52 (1997), pp. 1-28
[4]
J Barberá, G Peces-Barba, A Agustí, J Izquierdo, E Monsó, T Montemayor, et al.
Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol., 37 (2001), pp. 297-316
[5]
NM Siafakas, P Vermeire, NB Pride, P Paoletti, J Gibson, P Howard, et al.
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). European Respiratory Society consensus statement.
Eur Respir J., 8 (1995), pp. 1398-1420
[6]
V Snow, S Lascher, C Mottur-Pilson.
Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease.
Ann Intern Med., 134 (2001), pp. 595-599
[7]
PB Bach, C Brown, SE Gelfand, DC McCrory.
Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence.
Ann Intern Med., 134 (2001), pp. 600-620
[8]
JM Madison, RS Irwin.
Chronic obstructive pulmonary disease.
Lancet, 352 (1998), pp. 467-473
[10]
RA Pauwels, AS Buist, PM Calverley, CR Jenkins, SS Hurd.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
Am J Respir Crit Care Med., 163 (2001), pp. 1256-1276
[11]
NR Anthonisen, J Manfreda, CP Warren, ES Hershfield, GK Harding, NA Nelson.
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Ann Intern Med., 106 (1987), pp. 196-204
[12]
PA Sherk, RF Grossman.
The chronic obstructive pulmonary disease exacerbation.
Clin Chest Med., 21 (2000), pp. 705-721
[13]
DC McCrory, CD Brown.
Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease (Cochrane Review).
Cochrane Database Syst Rev., 2 (2001), pp. CD002984
[14]
JA Barberá, A Reyes, J Roca, JM Montserrat, PD Wagner, R Rodríguez-Roisin.
Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease.
Am Rev Respir Dis., 145 (1992), pp. 1328-1333
[15]
D Murciano, M Aubier, Y Lecocguic, R Pariente.
Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease.
N Engl J Med., 311 (1984), pp. 349-353
[16]
RG Barr, BH Rowe, CA Camargo.
Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials.
BMJ., 327 (2003), pp. 643
[17]
RS Irwin, JM Madison.
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
N Engl J Med., 348 (2003), pp. 2679-2681
[18]
DE Niewoehner, ML Erbland, RH Deupree, D Collins, NJ Gross, RW Light, et al.
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.
N Engl J Med., 340 (1999), pp. 1941-1947
[19]
CE McEvoy, DE Niewoehner.
Corticosteroids in chronic obstructive pulmonary disease. Clinical benefits and risks.
Clin Chest Med., 21 (2000), pp. 739-752
[20]
L Davies, RM Angus, PMA Calverley.
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised trial.
Lancet, 354 (1999), pp. 456-460
[21]
SD Aaron, KL Vandemheen, P Hebert, R Dales, IG Stiell, J Ahuja, et al.
Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.
N Engl J Med., 348 (2003), pp. 2618-2625
[22]
MA Jantz, SA Sahn.
Corticosteroids in acute respiratory failure. State of the art.
Am J Respir Crit Care Med., 160 (1999), pp. 1079-1100
[23]
F Maltais, J Ostinelli, J Bourbeau, AB Tonnel, N Jacquemet, J Haddon, et al.
Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.
Am J Respir Crit Care Med., 165 (2002), pp. 698-703
[24]
S Sethi.
Infectious etiology of acute exacerbations of chronic bronchitis.
Chest, 117 (2000), pp. 380S-385S
[25]
E Monsó, J Ruiz, A Rosell, J Manterola, J Fiz, J Morera, et al.
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.
Am J Respir Crit Care Med., 152 (1995), pp. 1316-1320
[26]
AS Banner.
Emerging role of corticosteroids in chronic obstructive pulmonary disease.
Lancet, 354 (1999), pp. 440-441
[27]
S Saint, S Bent, E Vittinghoff, D Grady.
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis.
JAMA, 273 (1995), pp. 957-960
[28]
J Eller, A Ede, T Schaberg, MS Niederman, H Mauch, H Lode.
Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function.
Chest, 113 (1998), pp. 1542-1548
[29]
F Álvarez, E Bouza, JA García- Rodríguez, MA Mayer, J Mensa, E Monsó, et al.
Uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol., 38 (2002), pp. 81-89
[30]
M Aubier, D Murciano, Y Lecocguic, N Viires, Y Jacquens, P Squara, et al.
Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure.
N Engl J Med., 313 (1985), pp. 420-424
[31]
JP Derenne, B Fleury, R Pariente.
Acute respiratory failure of chronic obstructive pulmonary disease.
Am Rev Respir Dis., 138 (1988), pp. 1006-1033
[32]
AM Schols, EF Wouters.
Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease.
Clin Chest Med., 21 (2000), pp. 753-762
[33]
M Greenstone.
Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev., (2000), pp. CD000223
[34]
PW Jones, M Greenstone.
Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease (Cochrane Review).
Cochrane Database Syst Rev., 1 (2001), pp. CD002881
[35]
GT Ferguson.
Update on pharmacologic therapy for chronic obstructive pulmonary disease.
Clin Chest Med., 21 (2000), pp. 723-738
[36]
AGN Agustí, M Carrera, F Barbé, A Muñoz, B Togores.
Oxygen therapy during exacerbations of chronic obstructive pulmonary disease.
Eur Respir J., 14 (1999), pp. 934-939
[37]
AP Jones, BH Rowe.
Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis.
Cochrane Database Syst Rev., (2000), pp. CD000045
[38]
MW Elliott, M Confalonieri, S Nava.
Where to perform noninvasive ventilation?.
Eur Respir J., 19 (2002), pp. 1159-1166
[39]
International Consensus Conferences in Intensive Care Medicine.
Noninvasive positive pressure ventilation in acute respiratory failure.
Am J Respir Crit Care Med., 163 (2001), pp. 283-291
[40]
JV Lightowler, JA Wedzicha, MW Elliott, FS Ram.
Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis.
BMJ., 326 (2003), pp. 185
[41]
MW Elliot.
Noninvasive ventilation in chronic ventilatory failure due to chronic obstructive pulmonary disease.
Eur Respir J., 20 (2002), pp. 511-514
[42]
SP Keenan, T Sinuff, DJ Cook, NS Hill.
Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive-pressure ventilation? A systematic review of the literature.
Ann Intern Med., 138 (2003), pp. 861-870
[43]
J Bott, MP Carroll, JH Conway, SE Keilty, EM Ward, AM Brown, et al.
Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease.
Lancet, 341 (1993), pp. 1555-1557
[44]
L Brochard, J Mancebo, M Wysocki, F Lofaso, G Conti, A Rauss, et al.
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.
N Engl J Med., 333 (1995), pp. 817-822
[45]
PK Plant, JL Owen, MW Elliott.
Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome.
Thorax, 56 (2001), pp. 708-712
[46]
F Barbé, B Togores, M Rubi, S Pons, A Maimo, AGN Agustí.
Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease.
Eur Respir J., 9 (1996), pp. 1240-1245
[47]
PK Plant, JL Owen, MW Elliott.
Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial.
Lancet, 355 (2000), pp. 1931-1935
[48]
N Kramer, TJ Meyer, J Meharg, RD Cece, NS Hill.
Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure.
Am J Respir Crit Care Med., 151 (1995), pp. 1799-1806
[49]
AS Slutsky.
Mechanical ventilation. American College of Chest Physicians' Consensus Conference.
Chest, 104 (1993), pp. 1833-1859
[52]
HH Webb, DF Tierney.
Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures. Protection by positive end-expiratory pressure.
Am Rev Respir Dis., 110 (1974), pp. 556-565
[53]
JM Sethi, MD Siegel.
Mechanical ventilation in chronic obstructive lung disease.
Clin Chest Med., 21 (2000), pp. 799-818
[54]
A Michelson, B Schuster, HD Kamp.
Paranasal sinusitis associated with nasotracheal and orotracheal long-term intubation.
Arch Otolaryngol Head Neck Surg., 118 (1992), pp. 937-939
[55]
PE Wright, JJ Marini, GR Bernard.
In vitro versus in vivo comparison of endotracheal tube airflow resistance.
Am Rev Respir Dis., 140 (1989), pp. 10-16
[56]
SJ Crogan, MJ Bishop.
Delivery efficiency of metered dose aerosols given via endotracheal tubes.
Anesthesiology, 70 (1989), pp. 1008-1010
[57]
AF Connors, DR McCaffree, BA Gray.
Effect of inspiratory flow rate on gas exchange during mechanical ventilation.
Am Rev Respir Dis., 124 (1981), pp. 537-543
[58]
TC Smith, JJ Marini.
Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction.
J Appl Physiol., 65 (1988), pp. 1488-1499
[59]
VM Ranieri, R Giuliani, G Cinnella, C Pesce, N Brienza, EL Ippolito, et al.
Physiologic effects of positive end-expiratory pressure in patients with chronic obstructive pulmonary disease during acute ventilatory failure and controlled mechanical ventilation.
Am Rev Respir Dis., 147 (1993), pp. 5-13
[60]
D Georgopoulos, E Giannouli, D Patakas.
Effects of extrinsic positive end-expiratory pressure on mechanically ventilated patients with chronic obstructive pulmonary disease and dynamic hyperinflation.
Intensive Care Med., 19 (1993), pp. 197-203
[61]
MJ Tobin.
Advances in mechanical ventilation.
N Engl J Med., 344 (2001), pp. 1986-1996
[62]
NR MacIntyre.
Respiratory function during pressure support ventilation.
Chest, 89 (1986), pp. 677-683
[63]
G Conti, D dell'Utri, V Vilardi, RA de Blasi, P Pelaia, M Antonelli, et al.
Propofol induces bronchodilation in mechanically ventilated chronic obstructive pulmonary disease (COPD) patients.
Acta Anaesthesiol Scand., 37 (1993), pp. 105-109
[64]
LB Santamaria, V Fodale, T Mandolfino, T Lucanto, I de Lieto Volaro, I Ballistreri, et al.
Transdermal scopolamine reduces nausea, vomiting and sialorrhea in the postoperative period in teeth and mouth surgery.
Minerva Anestesiol., 57 (1991), pp. 686-687
[65]
JP Kress, MF Pohlman, MF O'Connor, JB Hall.
Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.
N Engl J Med., 342 (2000), pp. 1471-1477
[66]
MH Kollef, NT Levy, TS Ahrens, R Schaiff, D Prentice, G Sherman.
The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation.
Chest, 114 (1998), pp. 541-548
[67]
CA Manthous, W Chatila, GA Schmidt, JB Hall.
Treatment of bronchospasm by metered-dose inhaler albuterol in mechanically ventilated patients.
Chest, 107 (1995), pp. 210-213
[68]
TG O'Riordan, MJ Greco, RJ Perry, GC Smaldone.
Nebulizer function during mechanical ventilation.
Am Rev Respir Dis., 145 (1992), pp. 1117-1122
[69]
R Dhand, AG Duarte, A Jubran, JW Jenne, JB Fink, PJ Fahey, et al.
Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients.
Am J Respir Crit Care Med., 154 (1996), pp. 388-393
[70]
JT Rabatin, PC Gay.
Noninvasive ventilation.
Mayo Clin Proc., 74 (1999), pp. 817-820
[71]
A Esteban, I Alia, F Gordo, R Fernández, JF Solsona, I Vallverdú, et al.
Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. The Spanish Lung Failure Collaborative Group.
Am J Respir Crit Care Med., 156 (1997), pp. 459-465
[72]
K Epstein S, RL Ciubotaru, JB Wong.
Effect of failed extubation on the outcome of mechanical ventilation.
Chest, 112 (1997), pp. 186-192
[73]
A Esteban, F Frutos, MJ Tobin, I Alia, JF Solsona, I Valverdú, et al.
A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group.
N Engl J Med., 332 (1995), pp. 345-350
[74]
S Nava, N Ambrosino, E Clini, M Prato, G Orlando, M Vitacca, et al.
Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial.
Ann Intern Med., 128 (1998), pp. 721-728
[75]
JH Gravil, OA Al Rawas, MM Cotton, U Flanigan, A Irwin, RD Stevenson.
Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service.
Lancet, 351 (1998), pp. 1853-1855
[76]
L Davies, M Wilkinson, S Bonner, PMA Calverley, RM Angus.
“Hospital at home” versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial.
BMJ., 321 (2000), pp. 1265-1268
[77]
MM Cotton, CE Bucknall, KD Dagg, MK Johnson, G MacGregor, C Stewart, et al.
Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.
Thorax, 55 (2000), pp. 902-906
[78]
E Sala, L Alegre, M Carrera, M Ibars, X Orriols, F Cárceles, et al.
Supported discharge shortens hospital stay in patients hospitalised because of an exacerbation of chronic obstructive pulmonary disease (COPD).
Eur Respir J., 17 (2001), pp. 1138-1142
[79]
T Pascual-Pape, JR Badia, RM Marrades, C Hernández, E Ballester, C Fornas, et al.
Resultados de dos programas con intervención domiciliaria dirigidos a pacientes con enfermedad pulmonar obstructivacrónicaevolucionada.
Med Clin (Barc), 120 (2003), pp. 408-411
[80]
C Hernández, A Casas, J Escarrabill, J Alonso, J Puig-Junoy, E Farrero, et al.
Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients.
Eur Respir J., 21 (2003), pp. 58-67
[81]
E Skwarska, G Cohen, KM Skwarski, C Lamb, D Bushell, S Parker, et al.
Randomised controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease.
Thorax, 55 (2000), pp. 907-912
[82]
AGN Agustí.
What's new in the COPD management?.
Monaldi Arch Chest Dis., 55 (2000), pp. 506-508
[85]
S Baudouin, S Blumenthal, B Cooper, C Davidson, A Davison, M Elliot, et al.
British Thoracic Society Standards of Care Committee. Non-invasive ventilation in acute respiratory failure.
Thorax, 57 (2002), pp. 192-211
[86]
MJ Baumel, RJ Schwab, RG Collman, L Brochard, J Mancebo.
Noninvasive ventilation for exacerbations of chronic obstructive pulmonary disease.
N Engl J Med., 334 (1996), pp. 735-736
[87]
European Respiratory Task Force on Epidemiology of Respiratory Intermediate Care in Europe.
Respiratory intermediate care units: a European survey.
Eur Respir J., 20 (2002), pp. 1343-1350
[88]
EH Elpern, MR Silver, RL Rosen, RC Bone.
The noninvasive respiratory care unit patterns of use and financial implications.
Chest, 99 (1991), pp. 205-208
Subsidized in part by ABEMAR and Red Respira (RTIC C03/11, Fondo de Investigación Sanitaria, Instituto de Salud Carlos III).
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
